Ruth Boyd and Margaret Grayson will present MErCuRIC as a case study in Patient and Public Involvement (PPI) in research at the European Alliance for Personalised Medicine Conference which is being held this week in Belfast, UK. The conference theme is ‘Personalising Your Health: A Global Imperative!’ and runs from 27- 30 November 2017.
Patient and Public Involvement (PPI) has become increasingly established as good practice in cancer research in the UK and, to various degrees, across Europe. INVOLVE defines PPI as ‘research being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them. ‘The Northern Ireland Cancer Research Consumer Forum (NICRCF), a group of over 20 people affected by cancer working with researchers, has been a partner group in two large research programmes; the European MErCuRIC project a multicenter phase Ib/II clinical trial assessing a novel drug combination of MEK and MET inhibitors in advanced colorectal cancer (CRC) and S: CORT– a Stratified Medicine Consortium in CRC. These projects are case studies in patient/carer partnerships in personalised and precision medicine (PPM) research.’
For more information for patients interested in MErCuRIC, please click here.
Download the poster here EAPM Final Poster.